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Background: In autosomal recessive early-onset Parkinsonism (PARK2), the pathogenetic process from the loss of
function of a ubiquitin ligase parkin to the death of dopamine neurons remains unclear. A dominant hypothesis
attributes the neurotoxicity to accumulated substrates that are exempt from parkin-mediated degradation. Parkin
substrates include two septins; SEPT4/CDCrel-2 which coaggregates with α-synuclein as Lewy bodies in Parkinson’s
disease, and its closest homolog SEPT5/CDCrel-1/PNUTL1 whose overload with viral vector can rapidly eliminate
dopamine neurons in rats. However, chronic effects of pan-neural overload of septins have never been examined in
mammals. To address this, we established a line of transgenic mice that express the largest gene product
SEPT454kDa via the prion promoter in the entire brain.
Results: Histological examination and biochemical quantification of SEPT4-associated proteins including α-synuclein
and the dopamine transporter in the nigrostriatal dopamine neurons found no significant difference between
Sept4Tg/+ and wild-type littermates. Thus, the hypothetical pathogenicity by the chronic overload of SEPT4 alone, if
any, is insufficient to trigger neurodegenerative process in the mouse brain. Intriguingly, however, a systematic
battery of behavioral tests revealed unexpected abnormalities in Sept4Tg/+ mice that include consistent attenuation
of voluntary activities in distinct behavioral paradigms and altered social behaviors.
Conclusions: Together, these data indicate that septin dysregulations commonly found in postmortem human
brains with Parkinson’s disease, schizophrenia and bipolar disorders may be responsible for a subset of behavioral
abnormalities in the patients.
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Quantitative dysregulation of septins, a family of poly-
merizing scaffold proteins, is frequently associated with
psychiatric disorders in humans. For instance, unbiased
proteomic analyses of postmortem brains from patients
with schizophrenia and bipolar disorder have uncovered
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distribution, and reproduction in any mediumdorsolateral prefrontal cortices [1] and scarcity of SEPT11
in the hippocampal CA2/3 regions [2]. The neuropsy-
chiatric significance of these phenomena is unknown.
On the other hand, occurrence of an excess of septins
has been hypothesized as a critical event that accompanies
a series of progressive degenerative processes in a subset
of Parkinson’s disease (PD). The potential toxicity of
septin overload is suggested by the following biochemical
evidence and findings from animal models: Two paralo-
gous septin subunits, SEPT5/CDCrel-1 [3] and SEPT4/
CDCrel-2 (misnamed as SEPT5_v2 in [4]) are the sub-
strates of ubiquitination by parkin, an E3 ubiquitin proteinCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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recessive early-onset parkinsonism (ARJP/PARK2) and a
subset of sporadic PD. When the parkin function is
abolished, the two septins are hypothesized to 1) accumu-
late with other non-septin substrates, 2) cause neuronal
dysfunction, and 3) trigger neuronal death. The first step
in this scenario is supported by the accumulation of
SEPT5/7/8/11 in the striata of parkin-null mice [5] and of
SEPT5 in dopamine neurons of transgenic mice that
express a dominant negative mutant of parkin [6]. In
humans, SEPT4 exceeds the normal level in the frontal
cortices of postmortem brains from patients with PARK2
and in the substantia nigra from several cases of sporadic
PD [4,7]. The second step is supported by the facts that
SEPT5 overexpression interferes with syntaxin-mediated
exocytosis from cultured cells [8,9], that parkin-null mice
exhibit reduced synaptic excitability of the striatal medium
spiny neurons and a mild motor coordination deficit [10],
and that the dominant-negative parkin transgenic mice
exhibit striatal dopamine excess and reduced voluntary
movement [6]. The third step is supported by a report that
dopamine neurons start to die within 15 days of the injec-
tion of SEPT5-expressing adeno-associated viral vector
into rat substantia nigra [9]. Meanwhile, other reports have
provided counter-evidence that dopamine neurons are
morphologically intact in parkin-null mice and dominant-
negative parkin transgenic mice [6,10], and that lentiviral
vector-mediated expression of SEPT5 in mice (to × 1.5 of
the endogenous level, co-expressed with green fluorescent
protein (GFP)) did not kill neurons [11]. Thus, the pre-
sumed neurotoxicity by an excess of SEPT5 and other
septins awaits further assessments with rigorous quantifi-
cation of the expression level.
SEPT4, the closest paralog of SEPT5 in the mammalian
genome, is unique among the septin family in several res-
pects: First, SEPT454kDa, the largest product from the
mouse Sept4 gene, contains an amino-terminal extension
of ~100 amino acid residues that shares no homology with
any polypeptide sequence in the database, followed by a ca-
nonical septin structure similar to SEPT5. Second, SEPT4,
not SEPT5, can associate directly with α-synuclein in a cer-
tain conformation ([12,13], data not shown). Third, SEPT4,
but not SEPT5, is an accessory component of α-synuclein
-based aggresomes known as Lewy bodies found in PD
and dementia with Lewy bodies, and as glial cytoplasmic
inclusions in multiple system atrophy [14]. Sept4-null mice
exhibit diminished dopaminergic neurotransmission due to
the scarcity of a set of presynaptic proteins for dopamine
turnover that include syntaxin-1, the dopamine transporter
(DAT), and α-synuclein (α-Syn), all of which are co-
immunoprecipitated from the striatal lysate with SEPT4
[12]. However, the effects of SEPT4 overload, either acute
or chronic, have never been tested in vivo either with
transgenic model or with viral vector-based model.On the basis of the above background, this study critic-
ally addressed the open questions through the assessment
of chronic effects of septin overload on neurodegeneration
and neural dysfunctions. To this end, we have established
three lines of transgenic mice that express SEPT454kDa in
the brain [12], of which the one with the best breeding
efficiency was used for this study (see Methods). The
transgenic and nontransgenic male littermate mice were
subjected to histochemical and biochemical analyses, and
to an unbiased, systematic behavioral test battery as a
means of sensitive functional screening.
Results
Generation and establishment of a transgenic mouse line
that stably expresses SEPT454kDa in the brain
To assess the hypothetical harm of chronic overload of
SEPT454kDa in mice, we constructed a transcription unit
by inserting the coding region of the mouse Sept4_v1
cDNA into the mouse PrP(prion gene promoter)-polyA
cassette which drives pan-neural gene expression [15].
We obtained transgenic mice by injecting the linearized
transcription unit into the oocytes of C57BL/6J mice
and selected founders that transmitted the transgene in
Mendelian manner. After backcrossing one of the foun-
ders and the offspring with wild-type C57BL/6 mice for
more than ten generations, we have established a trans-
genic line that consistently exhibits pan-neural expression
of exogenous SEPT454kDa in addition to the endogenous
Sept4 gene products, SEPT454/52/48/44kDa. In this study we
analyzed male mice heterozygous for the transgene
(Sept4Tg/+) with their wild-type male littermates (Sept4+/+)
at the age of 5–9 months.
Sept4Tg/+ and Sept4+/+ littermates did not show recog-
nizable differences in the whole body weight (31.0 g vs.
31.5 g; Additional file 1: Figure A1A) and in the gross
and histological brain architecture (Figure 1A left, data
not shown). We examined the spatial expression pattern
of the transgene-derived SEPT454kDa in parasagittal and
coronal brain sections by immunofluorescence with an
antibody H5C2U that recognizes a carboxyl-terminal
sequence shared by the major Sept4-derived polypeptides
including SEPT454kDa. The immunofluorescence signals
were more intense in Sept4Tg/+ brain sections than in
wild-type samples especially in the forebrain including the
hippocampus and the striatum, whereas the increment
was obscured by high endogenous signals in the thalamus,
midbrain, and other regions (Figure 1A right).
Quantitative expression analysis of transgenic SEPT454kDa
and the endogenous SEPT4 polypeptides in brain
subregions
We quantified the expression level of the endogenous
and transgenic SEPT4 polypeptides in the cerebral cor-
tex, striatum, midbrain/brainstem, and the cerebellum.
Figure 1 Expression of the endogenous and transgenic SEPT4 in the mouse brain. (A) Representative parasagittal brain sections of the
wild-type (wt, Sept4+/+) and transgenic (tg, Sept4Tg/+) adult male mice stained with hematoxylin and eosin (HE, left panels), or immunostained
for SEPT4 (right panels). In Sept4Tg/+ brain, the increment of SEPT4 is the most obvious where the endogenous SEPT4 expression is relatively low
(e.g., the striatum, hippocampus and cerebral cortex). No recognizable anatomical and histological difference was found between Sept4+/+
and Sept4Tg/+ brains. (B) Quantitative immunoblot analysis of the major SEPT4 polypeptides in fractionated lysates from Sept4+/+ and Sept4Tg/+
brain regions. (Top) Representative immunoblot patterns for SEPT4 and α-tubulin (loading control) of the following brain regions; the cerebral
cortex (cx), striatum (str), midbrain and brainstem (mb + bs), and cerebellum (cbl). The lysate (containing 3 μg protein) from each brain region
was separated by ultracentrifugation into the supernatant/soluble (s) fraction and the pellet/insoluble (p) fraction. Immunoblot with the SEPT4
antibody (used in panel A) consistently detected four major bands of approximately 54, 52, 48 and 44 kDa, all of which were absent in
Sept4−/− mice ([12]; data not shown). The top band, containing the transgene-encoded 54 kDa isoform was consistently increased in each
region of Sept4Tg/+ brain, reflecting the pan-neural expression by the prion promoter. (Bottom) Comparison of the total densitometric values of
the four major SEPT4 polypeptides in the two fractions of the brain regions. The ratio of soluble SEPT4 content of Sept4Tg/+ brain over Sept4+/+
brain was roughly x 1.5, except for the cerebellum.
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detected mainly four major bands of approximately 54, 48,
44 and 42 kDa in the soluble fractions extracted from the
four brain regions (‘s’ in Figure 1B, top). Each brain region
from Sept4Tg/+ mice exhibited specific abundance of
SEPT454kDa, corroborating the pan-neural expression of
transgenic SEPT454kDa as designed. In Sept4+/+ brain, the
insoluble fraction contained slightly more SEPT454kDa
than the soluble fraction except for the cerebellum. By
contrast, SEPT454kDa was partitioned predominantly into
the soluble fraction in Sept4Tg/+ brain. Thus, we speculatethat the excess SEPT454kDa is not organized into phy-
siological higher-order heteropolymers or aggregated into
inclusion bodies that cannot be extracted.
Densitometry revealed that the expression ratio of
SEPT454kDa in Sept4Tg/+ brain over Sept4+/+ brain was
the highest in the cerebral cortex (approximately × 8.5
in the soluble fraction), followed by the striatum (× 7),
cerebellum (× 6), and midbrain and brainstem (× 5).
These data appear to be compatible with the immunofluo-
rescence results (Figure 1A right). Although the functional
equivalence among the four major SEPT4 polypeptides is
Figure 2 Expression of the two major proteins for dopamine
metabolism and α-synuclein in the striata of wild-type and
Sept4 transgenic mice. (A) The nigrostriatal tract (parasagittal
sections) of Sept4+/+ and Sept4Tg/+ mice immunostained for the
dopamine transporter (DAT). There was no recognizable
morphological alteration in the nigrostriatal tract of Sept4Tg/+ mice.
(B–D) Quantitative immunoblot analysis for DAT, tyrosine
hydroxylase (TH), α-synuclein (α-Syn), and α-Syn phosphorylated at
Ser132 (p-α-Syn) in the fractionated lysate of the striata of Sept4+/+
and Sept4Tg/+ mice. There were no significant quantitative changes
in these proteins by the chronic overload of SEPT4.
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equally, the relative SEPT4 content in Sept4Tg/+ brain was
roughly × 1.5 of Sept4+/+ brain (Figure 1B, bottom). Thus,
the dosage of SEPT4 in our Sept4Tg/+ mouse brain is
comparable to those which would be caused by trisomies
involving the Sept4 gene locus (see Discussion).
Chronic SEPT454kDa overload does not affect the amount
and solubility of DAT, TH and α-synuclein in the striatum
Our previous study with Sept4−/− mice demonstrated a
significant attenuation of dopamine transmission in the
striatum, partly due to the combined scarcity of DAT, α-
Syn, and tyrosine hydroxylase (TH) in the axon terminals
of dopamine neurons without morphological alterations
[12]. Sept4Tg/+ mice did not exhibit recognizable morpho-
logical changes in the nigrostriatal tract up to light micro-
scopic level (DAT immunofluorescence in Figure 2A, data
not shown). Immunoblot analysis of the fractionated
lysates of the striatum showed no significant quantitative
changes in the amount and partitioning of DAT, TH, and
α-Syn in Sept4Tg/+ mice (Figure 2B–D). Further, α-Syn
phosphorylated at Ser132 (p-α-Syn), the aggregation-prone
species pathognomonic for synucleinopathies [16], was
not detected in Sept4Tg/+ striatum (Figure 2D). These bio-
chemical and morphological data indicate that aberrant
expression, modification or aggregation of these proteins
and obvious neurodegeneration do not occur in nigros-
triatal dopamine neurons in Sept4Tg/+ mice at least up to
9 months.
Sept4Tg/+ mice exhibit attenuation of activity surges in
distinct behavioral paradigms
As a means of unbiased, sensitive screening for neuro-
psychiatric abnormalities, Sept4Tg/+ mice were subjected
to a battery of behavioral tests. Overall, male Sept4Tg/+ and
Sept4+/+ littermates (n = 15 and 20) did not differ signifi-
cantly in their appearance and many of the quantitative
physical and behavioral indices measured (Table 1 and
Additional file 1: Figure A1–A11. The raw data are access-
ible at the Mouse Phenotype Database, http://www.mouse-
phenotype.org/). It is noteworthy that Sept4Tg/+ mice were
normal in prepulse inhibition (PPI) test (Additional file 1:
Figure A4) in contrast to Sept4−/− mice which demon-
strated a significant augmentation in PPI score [12].
Intriguingly, however, distinct behavioral paradigms
independently pointed to attenuations of voluntary loco-
motor activities of Sept4Tg/+ mice as follows: 1) Reduc-
tion in the distance traveled in the initial phase (p = 0.03
at 0–5 min; Figure 3A and 3B) of an open field test. 2)
Reduction in the center time (another index of explora-
tory activity) in an early time frame of an open field test
(p = 0.004 at 14–18 min; Figure 3C and D). 3) Sub-
normal trends in the open field test after driving the
activity with methamphetamine (MAP, injected at 60 min;Figure 4A and B. Note: Reduced sample numbers by split-
ting groups have reduced the power of statistical analysis.)
4) Reductions in the dark phase activity surges in the
home cage activity monitoring, the last of which ex-
tended to the first 45 min after the onset of the light
phase (p = 0.01; Figure 5A and B). 5) Consistent reduc-
tion of locomotor activities in the social interaction
tests (p = 0.038; Figure 6E; Additional file 1: Figure A7;
See below). These behavioral data commonly indicate that
the basal activity level of Sept4Tg/+ mice is maintained in a
normal range, while their induced activity upon environ-
mental, social, or pharmacological stimuli, or by circadian
Table 1 Summary of systematic behavioral tests for Sept4Tg/+ mice in comparison with Sept4−/− mice
Tests Mental/physical activities Indices measured Alteration from wildtype
(inexhaustive) Sept4tg/+(tg) Sept4−/−(ko)
Table 1. Summary of systematic behavioral
tests for Sept4Tg/+ (tg) mice in comparison
with Sept4−/− (ko) mice (Additional Figure A1)
General health Body weight → →
Rectal temperature → →
Grip strength → →
Hanging persistence → →
Light/dark transition test Exploratory activity Distance traveled in the light
chamber
→ →
(Additional Figure A2) Light avoidance Distance traveled in the dark chamber → →
Latency to the first entry to the
light chamber
→ →
Time stayed in the light chamber → →
Number of transitions between
chambers
→ →
Open field test Exploratory activity Distance traveled →* →
(Figure 3) Avoidance from open space Center time → →
Open field test + metamphetamine Induced surge of exploratory
activity
Distance traveled →* ↓
(Figure 4) Center time → N.D.
Elevated plus maze test Exploratory activity Distance traveled → →
(Additional Figure A3) Height avoidance Entries into open arms ↑ →
Number of entries → →
Time stayed on open arms → →
Acoustic startle response Startle reflex to loudness Ampliture of body motion → →
(Additional Figure A4A)
Prepulse inhibition (PPI) test Sensorimotor gating Decrement of startle amplitude → ↑
(Additional Figure A4B)
Porsolt forced swim test Despair-like behavior Latency to immobility → →
(Additional Figure A5)
Home cage monitoring Diurnal cycle of locomotor
activity
Activity level (distance traveled) → (basal) →
(Figure 5) ↓(at surges) →
Social interaction test Social behavior, anxiety-like
behavior
Distance traveled → →
(1 chamber, stranger pair) Number of contacts → →
(Additional Figure A7) Total duration of active contacts → →
Mean contact duration → →
Total duration of contacts → →
Social interaction test Social behavior, anxiety-like
behavior
Time spent with novel stranger ↓(Step 2) N.D.
(3 chamber, 1–2 caged strangers)
(Figure 6) Distance traveled ↓(Step 2) N.D.
Rota rod test Motor coordination/learning Latency to fall → →
(Additional Figure A6)
Beam test Motor coordination/learning Moving speed N.D. →
Gait analysis Mechanics of limb
movement
Limb positions and timings → (front paw angle) N.D.
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Table 1 Summary of systematic behavioral tests for Sept4Tg/+ mice in comparison with Sept4−/− mice (Continued)
(Additional Figure A8) ↓ (hind paw angle) N.D.
Hot plate test Aversive response to noxious
stimulus
Latency to limb withdrawal → →
(Additional 1 Figure A9)
Tail suspension test Behavioral despair Latency to immobility → →
(Additional 1 Figure A10)
Fear conditioning test Fear memory Conditioning → →
(Additional 1 Figure A11) Contextual testing → →
Cued test with altered context → →
Comparative table of systematic behavioral test results with Sept4Tg/+ (tg) and wild-type littermate male mice (C57BL/6, this study) and with Sept4−/− (ko) and
wild-type littermate male mice (C57BL/6J, [12]). Symbols: →, no significant difference (p > 0.05); ↑, statistically significant increase; ↓, statistically significant
decrease; in comparison with wildtype littermates. N.D., not determined.
Figure 3 Attenuation of the initial exploratory activity of Sept4Tg/+ mice in a novel environment. (A, B) The total distance traveled during
the entire session of 120 min (A, 5-min step) and an expansion of the initial 5 min (B, 1-min step) in the open field test. In the initial 5 min
(bar in A), the exploratory locomotive activity of Sept4Tg/+ mice was significantly less than that of Sept4+/+ mice (*, p = 0.032, n = 20, 14). The test
was conducted at the age of 6 months (cf. Figure 4). [(A) F1,32 = 0.09, p = 0.77, genotype × time interaction, F23,736 = 1.14, p = 0.29, (B) F1,32 = 5.04,
p = 0.032, genotype × time interaction, F4,128 = 2.86, p = 0.026.] (C, D) The center time during the entire session (C, 5-min step) and an expansion
of 14–18 min (D, 1-min step) of the open field test. The center time, another index of the exploratory activity, tended to be reduced in Sept4Tg/+
mice, which was statistically significant during an early time frame (**, p = 0.004). [(C) F1,32 = 0.45, p = 0.51, genotype × time interaction,
F23,736 = 0.63, p = 0.91, (D) F1,32 = 9.37, p = 0.004, genotype × time interaction, F4,128 = 0.39, p = 0.82].
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the hypoactivity of Sept4Tg/+ mice is context-dependent
or selective, given their normal locomotor activity in
the light/dark transition and elevated plus maze tests
(Additional file 1: Figure A2A and A3A).
Unique alterations in social behaviors in Sept4Tg/+ mice
Our unbiased behavioral screening detected unexpected
alterations in social activities of Sept4Tg/+ mice. In a para-
digm of social interaction test with a caged stranger
mouse in a three-compartment chamber [17,18], Sept4Tg/+
mice approached a caged stranger (S1) almost normally
(Figure 6A, Step1; Figure 6B). However, after subsequent
introduction of a second caged stranger (S2), Sept4Tg/+
mice approached S2 less frequently than their Sept4+/+
littermates did (p = 0.037; Figure 6C).
In a distinct paradigm of an open field-based social
interaction test with a pair of stranger mice (Additional
file 1: Figure A7A), Sept4Tg/+ mice in a chamber tended
to contact less frequently than Sept4+/+ pairs did
(Additional file 1: Figure A7C–E). A similar trend of
reduced body contact was observed when a pair of
Sept4Tg/+ mice were housed as cage-mates and moni-
tored for a week (data not shown).Figure 4 A trend of attenuation of the metamphetamine-induced hyp
Sept4+/+ and Sept4Tg/+ mice to the administration of a dopaminergic psych
The test was conducted with the same cohort of 9-month-old mice in the
level before MAP injection while extending the center time.). Each of the S
intraperitoneally injected with either MAP in saline (open and closed circle
and observed for 120 min. The metamphetamine-driven surge of the total
to be less than those of Sept4+/+ mice. [(A) F1,29 = 0.53, p = 0.47, drug effec
p = 0.72, genotype × time interaction, F23,667 = 1.13, p = 0.31, drug × time in
interaction, p = 0.46, (B) F1,29 = 0.92, p = 0.35, drug effect, F1,29 = 19.37, p = 0
time interaction, F23,667 = 1.34, p = 0.13, drug × time interaction, F23,667 = 7.4Other behavioral alterations found in Sept4Tg/+ mice
The behavioral screening identified some other alterations
in Sept4Tg/+ mice in distinct paradigms as follows: 1) In the
elevated plus maze test, Sept4Tg/+ mice entered the open
arms significantly more often (p = 0.02; Additional file 1:
Figure A3C) and tended to stay there longer than the
control mice (Additional file 1: Figure A3D). 2) In a
treadmill-based, video-assisted gait pattern analysis using
DigiGait [19], Sept4Tg/+ mice exhibited significantly
narrower hind paw splay angle, i.e., toe-in (p = 0.001;
Additional file 1: Figure A8F), without alterations in the
other indices of gait mechanics.
Discussion
Chronic overload of SEPT4 alone is insufficient to cause
neurodegeneration in mice
A widely accepted hypothesis proposed for PARK2 in
humans attributes the degeneration of dopamine neu-
rons by the loss of parkin function to the accumulation
of its ubiquitination substrates that include Pael recep-
tor/GPR37, SEPT4, SEPT5, syphilin-1, cyclin E, and
aminoacyl-tRNA synthetase cofactor p38 [20]. Potential
neurotoxicity of some of these substrates has been
demonstrated by the viral vector-mediated rat models oreractive responses in Sept4Tg/+ mice. (A, B) The responses of
ostimulant metamphetamine (MAP) assessed in the open field test.
same apparatus (cf. Figure 3. Note that aging has reduced the activity
ept4+/+ and Sept4Tg/+ cohorts was divided into two subgroups and
s, n = 10, 7) or saline (open and closed triangles, n = 9, 7) at 60 min
distance traveled (A) and the center time (B) of Sept4Tg/+ mice tended
t, F1,29 = 30.14, p < 0.0001, genotype × drug interaction, F1,29 = 0.13,
teraction, F23,667 = 8.28, p < 0.0001, genotype × drug × time
.0001, genotype × drug interaction, F1,29 = 0.62, p = 0.44, genotype ×
9, p < 0.0001, genotype × drug × time interaction, p = 0.21].
Figure 5 Attenuated diurnal activity surges of Sept4Tg/+ mice.
(A) Diurnal oscillation of the locomotor activity in the home cage
contained three peaks in Sept4+/+ mice during the dark phase, two
of which were significantly attenuated in Sept4Tg/+ mice (*, p = 0.01,
n = 9, 6). (B) An expansion of a time block during 7:00–8:00 in 5-min
step shows that the significant difference in activity lasted up to
45 min after the onset of the light phase. [F1,14 = 8.77, p = 0.010,
genotype × time interaction, F11,154 = 5.26, p < 0.0001].
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previous studies with other substrates, this study de-
monstrated for the first time that mice genetically
overloaded with SEPT4 do not develop obvious neuro-
degeneration or sensorimotor impairments at least up to
9 months of age. We regard the results as counter-
evidence against potential neurotoxicity of SEPT4 over-
load. However, our results do not exclude the possibility
that neurodegeneration triggered by other factors could
be aggravated by concurrent SEPT4 overload, or that
combined overload of the above substrates including
SEPT4 could entail “synthetic lethality”.
Differential suppression of dopaminergic
neurotransmission and/or behavioral activity by the loss
or excess of SEPT4
Our previous study demonstrated mild hypo-dopaminergic
abnormalities of Sept4−/− mice in two distinct behavioral
paradigms: 1) Excess in the PPI of acoustic startle response,
which was apparently normalized by apomorphine, a
nonselective agonist of dopamine receptors. 2)Attenuation in the methamphetamine-driven surge of
voluntary locomotion in an open field test. Consist-
ently, SEPT4-interacting presynaptic proteins including
DAT, syntaxin-1 and α-Syn were significantly reduced
in nigrostriatal dopamine neurons of Sept4−/− mice.
Thus, SEPT4 is regarded as a critical subunit of septin
hetero-oligomers that constitute presynaptic scaffold in
dopamine neurons [12]. However, the present study has
demonstrated that Sept4Tg/+ mice do not exhibit the
opposite phenotype in terms of behavior (e.g., PPI and
amphetamine-driven surge of locomotion) and prote-
ome (e.g., DAT in the striatum). Thus, a chronic excess
of SEPT4 alone is insufficient to trigger hyperactivity by
augmenting dopaminergic neurotransmission. Unexpec-
tedly, the SEPT4 overload entailed selective hypoactive
alterations in Sept4Tg/+ mice. Although the molecular
mechanism is currently unknown, we speculate that
excess SEPT4 may interfere with the exocytic machinery
by sequestering syntaxins as with other septin subunits
[8]. This possibility is supported by the normal levels of
dopamine and its major metabolites in Sept4Tg/+ striatum
(data not shown).
The unexpected concordance between Sept4−/− and
Sept4Tg/+ mice in terms of voluntary activity level indi-
cates that induced surges of dopaminergic neurotrans-
mission require SEPT4 to be in an optimal dose range;
either loss or excess could attenuate the maximal, but
not the basal, voluntary activity of an animal. Similar sit-
uations may occur in human chromosome duplications
involving 17q22 [25,26], in which three copies of SEPT4
genes theoretically cause × 1.5 overload of the normal
protein level. Likewise, dysregulation (mostly overload)
of diverse septin subunits frequently found in the post-
mortem brains from patients with schizophrenia and
bipolar disorder [1,2] may contribute to a subset of psy-
chiatric symptoms.
Could chronic overload of SEPT5 be responsible for the
hyperactivity in mice?
Copy number variations involving the human chromosome
locus 22q11.2 are associated with diverse developmental
disorders such as DiGeorge syndrome and Emanuel syn-
drome, which are often accompanied by neuropsychiatric
symptoms [27,28]. BAC transgenic mice that harbor
a ~200 kb subregion in the locus, containing several genes
including SEPT5, exhibited hyperactivity and other beha-
vioral abnormalities [29,30]. On the other hand, lentiviral
vector-mediated local expression of SEPT5 in the dorsal
hippocampi or basolateral amygdalae did not alter the vol-
untary locomotor activity of mice in an open field test [11].
Given the structural similarity between SEPT5 and SEPT4,
we speculate that chronic pan-neural expression of SEPT5
would entail a phenocopy of Sept4Tg/+ mice, with an atten-
uated voluntary locomotor activity via the aforementioned
Figure 6 Altered social interaction pattern of Sept4Tg/+ mice. (A) Schematic diagrams of the three-chamber sociability and social novelty
preference tests [18]. (Left) The sociability test setup. Each mouse was scored for the time spent in the middle habituated chamber (M), the left
chamber containing an unfamiliar C57BL/6J mouse (Stranger 1, S1) in a wire cage, or the right chamber with an empty wire cage (E). (Right)
The social novelty preference test following the sociability test uses the same apparatus, except for a novel unfamiliar C57BL/6J mouse (Stranger 2, S2)
caged in the right chamber in addition to the now-familiar C57BL/6J mouse (Stranger 1, S1) remaining in the left cage/chamber. (B, D) There
was no difference in the sociability indices (S1 over E) between the genotypes. [(B) F1,32 = 1.68, p = 0.20, (D) F1,32 = 4.75, p = 0. 037]. (C, E) In
the social novelty preference test (Step2) after the sociability test (Step1), Sept4Tg/+ mice exhibited significantly less preference for S2 over S1
than Sept4+/+ mice, indicative of their reduced curiosity in the novel social stimuli and/or augmented persistence to the familiar social stimuli
(n = 20, 14). [(C) F1,32 = 3.06, p = 0.09, (E) F1,32 = 4.69, p = 0. 038].
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http://www.molecularbrain.com/content/6/1/35interference on the exocytic machinery [31]. If so, the
hyperactivity of the BAC transgenic mice should be as-
cribed to a gene(s) other than SEPT5. This hypothesis is to
be critically tested either by chronic overload of SEPT5
alone in Sept5 transgenic mice, or by reducing the dosage
of SEPT5 from the BAC transgenic mice by intercrossing
them with Sept5-null mice [32,33].Involvement of septins in social behaviors
Positive correlation between the levels of septin expres-
sion and social interaction has been suggested by the fol-
lowing pieces of evidence: 1) Scarcity of SEPT5 in the
presynaptic varicosities in the striata of rats that had
been reared in social isolation [34]. 2) Reduced social
interaction in Sept5-null mice (Note: The phenotype is
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social interaction after the local expression of SEPT5 in
the basolateral amygdalae [11]. In contrast, stranger pairs
of Sept4Tg/+ mice tended to contact less frequently than
those of Sept4+/+ mice did (Additional file 1: Figure A7).
Further, Sept4Tg/+ mice approached novel stranger (S2)
less frequently than Sept4+/+ mice (Figure 6). Although
the underlying mechanisms are currently unknown, the
unique phenotype of Sept4Tg/+ mice may indicate their
attenuated novelty-seeking behaviors, as with the afore-
mentioned reduction of exploratory activities, which com-
monly depend on dopaminergic neurotransmission.Conclusions
As opposed to the prevalent but unproven notion that
accumulation of parkin substrates could cause neurode-
generation, our results would make a case against a
hypothesis that chronic overload of SEPT4 as a major
neurotoxic factor in Parkinson’s disease. However, as the
first genetic model of pure septin overload, Sept4Tg/+
mice with the intriguing behavioral phenotype should
provide a partial model for human chromosome dupli-
cations involving 17q22, and for psychiatric symptoms
in patients with septin dysregulations that frequently
accompany schizophrenia and bipolar disorder.Materials and methods
Generation and establishment of a line of transgenic mice
that overexpress SEPT454kDa
To generate transgenic mice that overexpress mouse
SEPT454kDa in the brain, mouse Sept4_v1 cDNA was
inserted between 5’- and 3’-untranslated regions of the
mouse prion protein transcription unit (MoPrP) containing
the brain-specific promoter [15]. The linearized MoPrP-
Sept4 transcription unit was injected into C57BL/6J
mouse oocytes, with or without co-injection of a linearized
CMV-driven expression plasmid for GFP as a transgenic
marker. Genotyping was determined by polymerase
chain reaction for an artificial sequence near the
MoPrP-Sept4 junction. Three transgenic lines that
expressed comparable levels of exogenous SEPT454kDa in
the brain, with or without systemic GFP expression, had
been established. The two lines of MoPrP-Sept4; CMV-
GFP were previously used for transgenic rescue experi-
ments of Sept4−/− mice [12]. In the present study, the third
line without GFP had been selected for robust fertility,
and backcrossed with C57BL/6 mice for more than 10
generations, when consistent Mendelian transmission
of the transgene was observed. Sept4Tg/+ and control
wild-type (Sept4+/+) mice for behavioral analyses were
bred as littermates from Sept4Tg/+ and wild-type pairs.
The third transgenic line was deposited to RIKEN
Bioresource Center (RBRC03800).Animals and experimental design
All animal procedures for breeding, behavioral tests,
and tissue sampling were conducted in accordance
with the guidelines of the Animal Use and Care Com-
mittees of Kyoto University, Nagoya University, and
the National Institute for Physiological Sciences. All
comparisons were made between male littermates to
minimize confounding effects of different genetic back-
ground and environment. All behavioral tests were
conducted when the mice were 5–9 months old as de-
scribed previously [36,37]. Mice were group housed (4
mice per cage) in a specific pathogen-free room kept at
23 ± 2°C with a 12-hr light/dark cycle (lights on at 7 a.m.)
with access to food and water. Behavioral testing was
conducted between 9 a.m. and 6 p.m. except for the home
cage social interaction monitoring. After each test, all ap-
paratuses were cleaned with sodium hypochlorite solution
to minimize odor.
The behavioral tests were conducted in the following
order: general health and neurological screening (inclu-
ding body weight and temperature measurements, grip
strength test, and righting, whisker touch, and ear twitch
reflexes), wire hang test, light/dark transition test, open
field test, elevated plus maze test, rotarod test, hot plate
test, one-chamber social interaction test, Crawley's
sociability and preference for social novelty test, acoustic
startle response/PPI test, Porsolt forced swim test, gait
analysis, fear conditioning test, tail suspension test, long-
term monitoring of locomotion and social interaction in
home cage, and open field test with methamphetamine.
Intervals between tests were >24 h.
Neuromuscular strength tests
Neuromuscular strength was assessed with the forelimb
grip strength test and wire hang test. Forelimb grip
strength was measured by pulling a mouse in the tail
while its forepaws hung on to a wire grid attached to a
spring balance (O’Hara & Co.). The peak force (N) until
each mouse released the grid was measured three times,
and the greatest value was statistically analyzed. In the
wire hang test, a wire mesh with a mouse on top was
slowly inverted and the latency to fall was measured with
a cut-off time of 60 s.
Light/dark transition test
The apparatus had a pair of differentially illuminated
(390 lux vs. 2 lux) chambers (21 × 41 × 25 cm) connected
with a door in the middle. Each mouse was released in
the dark chamber, and image data were acquired from
the top with a CCD camera for 10 min. The latency until
the first entry into the light chamber, the time spent in
each chamber, the number of transitions, and the total
distance traveled were automatically measured using
ImageLD software (see Image analysis) [36].
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Voluntary locomotor activity was measured in an open
field test. Each mouse was placed in the center of the open
field apparatus (40 × 40 × 30 cm; Accuscan Instruments)
illuminated at 100 lux. The following indices were moni-
tored for 120 min; total distance traveled, rearing (labeled
as vertical activity) measured by counting the number of
photobeam interruptions, time spent in the center area of
20 × 20 cm, and the beam-break counts (labeled as
stereotyped behaviors). After the completion of the
battery of behavioral tests, the mice of each genotype
randomly split into two groups were assessed likewise
from 1 h before through to 2 h after the intraperitoneal
injection of saline with or without methamphetamine
(MAP, 3 μg/g body weight).
Elevated plus maze test
The apparatus had two open arms (25 × 5 cm, with 3-
mm-high plastic ledges) and two closed arms (25 × 5 cm,
with 15-cm-high transparent walls) interconnected via a
central crossing (5 × 5 cm), which was set at 55 cm-height
and illuminated at 100 lux. The numbers of entries into,
and the time spent in the open and enclosed arms, were
recorded for 10 min. Image data were acquired from the
top with a CCD camera, and the number of entries into
and the time spent in the open/closed arms, and total
distance traveled (cm) were measured automatically using
ImageEP software (see Image analysis) [38].
Rota-rod test
Motor coordination and motor leaning were tested by
measuring the survival duration of keeping pace with a
3-cm-thick rotating rod which was accelerated from 4 to
40 rpm over 5 min (Rota-rod, UGO Basile). Each mouse
was subjected to 6 trials over 2 days.
Hot plate test
Sensitivity and responsiveness to a noxious stimulus was
represented by the latency to the first response after
placing mice on 55°C-plate (Columbus Instruments).
One-chamber social interaction test
The positions of two mice placed in a novel chamber
(40 × 40 × 30 cm) were monitored from the top at 1
frame/sec. Their horizontal distance traveled and the
number of contacts were measured automatically using
ImageSI software (see Image analysis).
Crawley's test for sociability and preference for social
novelty
The test was conducted as described [17,18]. The ap-
paratus had three chambers (20 × 40 × 22 cm) separated
by two transparent partitions each with an opening
(5 × 3 cm), and a lid with an infrared CCD camera. Amale mouse (8–12 weeks old C57BL/6J, termed Stranger
1) that had no prior contact with the subject mice was
enclosed in a cylinder cage (9 cm ϕ, set in the left
chamber) that allowed nose contacts. The subject mouse
was released in the middle chamber and allowed to
explore for 10 min, while the time spent in each chamber
and within 5 cm from each cage was measured auto-
matically using ImageCSI software (see Image analysis).
Subsequently, another unfamiliar mouse (Stranger 2) was
placed in another cylinder cage (in the right chamber) and
monitored likewise for another 10 min. One-way ANOVA
was applied for the statistical analysis for the comparison
within each genotype (e.g., Empty vs. Stranger 1, and
Stranger 1 vs. Stranger 2).
Acoustic startle response and PPI test
A mouse restrained in a cylinder was placed in the cham-
ber of a startle reflex measurement system (O'Hara & Co.)
with 70 dB background white noise. After 10 min, the
mouse’s startle response to a startle stimulus (40 ms of
110 or 120 dB white noise) was measured by a motion
sensor for 140 ms (temporal resolution, 1 ms). A test ses-
sion was a random sequence of four trials with a prepulse
stimulus (40 ms of 74 or 78 dB white noise 100 ms prior
to a startle stimulus) and two without. Six blocks of 6 trial
types were presented in pseudorandom order with the
average inter-trial interval of 15 s.
Porsolt forced swim test
Each mouse was placed in 7.5-cm-deep water at 23°C in
an acrylic cylinder (10 cm ϕ), and the duration of the
struggle for evacuation was measured up to 10 min auto-
matically using ImagePS software (see Image analysis).
Gait analysis
Automated gait analysis on a treadmill was conducted
with DigiGait (Mouse Specifics Inc.). Each mouse was
forced to walk on a treadmill moving at 24 cm/sec, when
the mouse body movement and paw footprints were
recorded at 150 frames/sec with a CCD camera under-
neath the treadmill. Multiple quantitative parameters
(length, width and timing of the strides, paw angle etc.)
were extracted from the time-lapse images with bundled
software.
Contextual and cued fear conditioning test
Each mouse was exposed to a test chamber (26 × 34 ×
33 cm) for 2 min, then to three pairs of a cue (55 dB white
noise for 30 sec) each followed by a mild footshock
(0.3 mA for 2 sec), repeated at 2-min intervals. For the
context testing after 1 or 8 days, freezing was measured in
the same chamber. For the cued testing in a distinct
spatial context after 1 or 8 days, freezing after the noise
was measured in a triangular chamber (35 × 35 × 41 cm)
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acquisition at 1 frame/sec from the top, and image ana-
lysis were done automatically with ImageFZ software
(see Image analysis). The criterion of freezing was
defined when the difference of binarized mouse areas
from two consecutive frames was below 10 pixels and
lasted for 2 sec or longer.
Tail suspension test
The behavior of each mouse suspended by the tail at a
height of 30 cm was recorded for 10 min and analyzed
using ImageTS software (see Image analysis).
Monitoring voluntary activity in the home cage
The position of each mouse housed alone in a cage was
monitored from the top continuously for a week. The
total distance traveled was measured automatically using
ImageHA software (see Image analysis).
Image analysis
The application programs for behavioral data acquisi-
tion and analysis (ImageLD, EP, CSI, PS, FZ, TS, HA)
were created on the platform of NIH Image (http://rsb.
info.nih.gov/nih-image/) and ImageJ (http://rsb.info.nih.
gov/ij/) by TM.
Antibodies
SEPT4 antibody (H5C2) had been raised against the
carboxyl terminus of mouse SEPT454kDa/SEPT4_v1 [14],
and the specificity had been confirmed by the absence of
the major signals in Sept4−/− mouse brain sections [12].
Commercial antibodies were used for the following
proteins: TH and DAT (AB1542 and MAB369, Chemicon/
Millipore), α-synuclein (Clone 42, BD), pSer129α-synuclein
(Wako), and α-tubulin (Sigma). For immunofluorescence,
Alexa 488- or 594-conjugated secondary antibodies against
rabbit or mouse IgGs (Molecular Probes/Invitrogen) were
used. The band patterns in immunoblot and the staining
pattern in immunofluorescence were consistent with previ-
ous independent studies with these antibodies [39].
Histochemistry, immunofluorescence and microscopy
Mouse brains were dissected after deep anesthesia with
sodium pentobarbital (50 μg/g, i.p.) with transcardial
perfusion with 0.01 M phosphate-buffered saline (PBS).
For histological analysis, mice were further perfused with
4% paraformaldehyde and 0.2% picric acid in 0.1 M PBS.
Hematoxylin/eosin stain and immunofluorescence was
performed on formaldehyde-fixed 30 μm-thick floating
brain sections, as previously described [40]. Specimens
were observed with a 20× objective lens (UPlanApo,
NA 0.7, Olympus) and a CCD camera (Retiga EXi, Q
Imaging) attached to an upright microscope (BX-60,
Olympus). A CCD microscope (BZ-9000, Keyence) witha 40× objective lens (Plan Apo, NA 1.3, Nikon) was used
for semi-automatic scanning and tiling of bright-field
and fluorescence images.
Biochemical fractionation of brain subregions by graded
extraction
The cerebral cortex, striatum, midbrain and brainstem,
and cerebellum from Sept4Tg/+ and wild-type littermate
mice (3–7 m.o.) were dissected, weighed, homogenized
by sonication in 3 ml/g of buffer A (10 mM Tris–HCl at
pH 7.5, 0.15 M NaCl, 1% Triton X-100, and protease
inhibitors). The supernatant after centrifugation at
20,400 × g at 4°C for 0.5 h was labeled as soluble frac-
tion. The washed pellet was dissolved with sonication in
buffer B (50 mM Tris–HCl pH 6.8, 2% SDS, 10% gly-
cerol), whose final volume was adjusted to that of the
cognate soluble fraction, and was labeled as pellet/insol-
uble fraction.
Immunoblotting, signal detection, densitometry
The protein content in each fraction was measured and
incubated with Laemmli buffer. Each soluble fraction
was loaded with the equivalent amount of the cognate
pellet/insoluble fraction in an adjacent lane of 8% or
10% polyacrylamide gel. Polypeptides resolved by elec-
trophoresis were transferred onto reinforced nitrocellu-
lose membranes (Whatman). The membranes were
blocked with 5% skim milk in Tris-buffered saline (TBS;
100 mM Tris–HCl at pH 7.4, 150 mM NaCl) containing
0.05% Tween-20 and incubated serially with the primary
antibodies and anti-rabbit or -mouse IgG conjugated
with horseradish peroxidase (Jackson ImmunoResearch).
After extensive wash with TBS plus 0.05% Tween-20,
chemiluminescence detection and densitometry were
conducted with ECL-Plus reagent (PerkinElmer) and an
image analyzer LAS 4000 mini with MultiGauge soft-
ware (GE).
Statistical analysis
Quantitative data were expressed as mean ± SEM. For
statistical analyses, either two tailed t-test or ANOVA
(one-way, two-way repeated measures, and repeated
measures with two factors) were applied using StatView
(SAS institute). F and p values represent the effects of
genotype unless otherwise noted (Figures 3–6).
Additional file
Additional file 1: Overall, quantitative data were expressed as
mean ± SEM, and either one-way or two-way repeated measures
ANOVA was applied for statistical analyses. F and p values represent
the effects of genotype unless otherwise noted. Figure A1. Normal body
weight, rectal temperature, and muscle strength of Sept4Tg/+ mice.
Figure A2. Normal locomotor activity of Sept4Tg/+ mice in the light/dark
transition test. Figure A3. Reduced anxiety-like behavior of Sept4Tg/+
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response and normal sensorimotor gating of Sept4Tg/+ mice in the
prepulse inhibition (PPI) test. Figure A5. Normal depression-like behavior
of Sept4Tg/+ mice in Porsolt forced swim test. Figure A6. Normal motor
coordination and motor learning of Sept4Tg/+ mice in the rotating rod
test. Figure A7. Reduced physical contact between pairs of Sept4Tg/+
mice in an open field. Figure A8. Reduced hind paw splay angle of
Sept4Tg/+ mice in the gait analysis. Figure A9. Normal responsiveness of
Sept4Tg/+ mice toward noxious stimuli in the hot plate test. Figure A10.
Normal depression-like behavior of Sept4Tg/+ mice in the tail suspension
test. Figure A11. Normal contextual and cued fear conditioning of
Sept4Tg/+ mice.
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